For the first time, the federal government is allowed to negotiate drug prices for older Americans. Medicare will name the first 10 drugs by Friday.
Author: Ken Alltucker, USA TODAY
Esai and Biogen, Lequembi manufacturer, receive FDA approval for Alzheimer’s drug
Eisai and Biogen’s drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA’s full review.
Fourth of July fireworks come as some parts of US are ‘primed to burn’
Experts warn hot, dry conditions are ripe for wildfires ahead of Fourth of July celebrations. Some cities turn to drone light displays to curb risk.
Drugmaker Merck sues the Biden administration over Medicare’s drug price negotiations
Merck said the price negotiations are a ‘sham’ that compel drugmakers to accept lower prices, according to a lawsuit.
FDA seeks to ease cancer drug shortage with China-made imports
More than one dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin. U.S. eases import restrictions.
How the US reports COVID data is about to change. Here’s what you need to know.
As the public health emergency ends May 11, the CDC will change how it reports COVID data and will no longer be counting every case.
Cease-fire in Sudan extended three days, Secretary of State Antony Blinken says: Live updates
The U.S. has deployed intelligence, surveillance and reconnaissance assets to aid people traveling by land from Khartoum to the Port of Sudan.
As states cut Medicaid, some fear they’ll mistakenly end coverage for millions of eligible people
States are resuming Medicaid eligibility checks that were paused during the COVID public health emergency.
A billing dispute means a mom must pay nearly $1,000 a month for her son’s diabetes care
A New York family’s struggle to get care is an example of how difficult it can be for people to afford the cost of medical care needed for diabetes.
3 major insulin makers have now slashed the price of the life-saving drug. Here’s why.
Sanofi on Thursday became the last major insulin maker to cut the price of the life-saving drug. Here’s why it’s been so expensive and what’s next.